Effects of Low Dose Naltrexone on Quality of Life in High Grade Glioma Patients: A Placebo-Controlled, Double-Blind Randomized Trial
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2015
At a glance
- Drugs Naltrexone (Primary) ; Temozolomide
- Indications Glioma
- Focus Pharmacodynamics; Therapeutic Use
- 25 Jun 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.
- 12 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov
- 15 Jan 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Sep 2014 to 1 Dec 2014.